92 related articles for article (PubMed ID: 10454479)
1. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.
Martin BR; Jefferson R; Winckler R; Wiley JL; Huffman JW; Crocker PJ; Saha B; Razdan RK
J Pharmacol Exp Ther; 1999 Sep; 290(3):1065-79. PubMed ID: 10454479
[TBL] [Abstract][Full Text] [Related]
2. Potent cyano and carboxamido side-chain analogues of 1', 1'-dimethyl-delta8-tetrahydrocannabinol.
Singer M; Ryan WJ; Saha B; Martin BR; Razdan RK
J Med Chem; 1998 Oct; 41(22):4400-7. PubMed ID: 9784115
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
Melvin LS; Milne GM; Johnson MR; Subramaniam B; Wilken GH; Howlett AC
Mol Pharmacol; 1993 Nov; 44(5):1008-15. PubMed ID: 8246904
[TBL] [Abstract][Full Text] [Related]
4. Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids.
Papahatjis DP; Nahmias VR; Andreou T; Fan P; Makriyannis A
Bioorg Med Chem Lett; 2006 Mar; 16(6):1616-20. PubMed ID: 16387492
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.
Papahatjis DP; Kourouli T; Abadji V; Goutopoulos A; Makriyannis A
J Med Chem; 1998 Mar; 41(7):1195-200. PubMed ID: 9544219
[TBL] [Abstract][Full Text] [Related]
6. Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs.
Busch-Petersen J; Hill WA; Fan P; Khanolkar A; Xie XQ; Tius MA; Makriyannis A
J Med Chem; 1996 Sep; 39(19):3790-6. PubMed ID: 8809166
[TBL] [Abstract][Full Text] [Related]
7. Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'.
Papahatjis DP; Nikas SP; Kourouli T; Chari R; Xu W; Pertwee RG; Makriyannis A
J Med Chem; 2003 Jul; 46(15):3221-9. PubMed ID: 12852753
[TBL] [Abstract][Full Text] [Related]
8. Role of cannabinoid receptors in inhibiting macrophage costimulatory activity.
Chuchawankul S; Shima M; Buckley NE; Hartmann CB; McCoy KL
Int Immunopharmacol; 2004 Feb; 4(2):265-78. PubMed ID: 14996418
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of indole- and pyrrole-derived cannabinoids.
Wiley JL; Compton DR; Dai D; Lainton JA; Phillips M; Huffman JW; Martin BR
J Pharmacol Exp Ther; 1998 Jun; 285(3):995-1004. PubMed ID: 9618400
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency.
Thomas BF; Compton DR; Martin BR
J Pharmacol Exp Ther; 1990 Nov; 255(2):624-30. PubMed ID: 2173751
[TBL] [Abstract][Full Text] [Related]
11. C1'-cycloalkyl side chain pharmacophore in tetrahydrocannabinols.
Papahatjis DP; Nahmias VR; Nikas SP; Andreou T; Alapafuja SO; Tsotinis A; Guo J; Fan P; Makriyannis A
J Med Chem; 2007 Aug; 50(17):4048-60. PubMed ID: 17672444
[TBL] [Abstract][Full Text] [Related]
12. Novel pyrazole cannabinoids: insights into CB(1) receptor recognition and activation.
Wiley JL; Jefferson RG; Grier MC; Mahadevan A; Razdan RK; Martin BR
J Pharmacol Exp Ther; 2001 Mar; 296(3):1013-22. PubMed ID: 11181936
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship of substitutions at the C-1 position of Delta9-tetrahydrocannabinol.
Burdick D; DeOrazio R; Guzzo P; Habershaw A; Helle M; Paul B; Wolf M
Bioorg Med Chem Lett; 2010 Feb; 20(4):1424-6. PubMed ID: 20079638
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
15. Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues.
Griffin G; Williams S; Aung MM; Razdan RK; Martin BR; Abood ME
Br J Pharmacol; 2001 Jan; 132(2):525-35. PubMed ID: 11159703
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and psychotropic activity of side-chain hydroxylated delta6-tetrahydrocannabinol metabolites.
Ohlsson A; Agurell S; Leander K; Dahmén J; Edery H; Porath G; Levy S; Mechoulam R
Acta Pharm Suec; 1979; 16(1):21-33. PubMed ID: 110030
[No Abstract] [Full Text] [Related]
17. Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation.
Berglund BA; Fleming PR; Rice KC; Shim JY; Welsh WJ; Howlett AC
Drug Des Discov; 2000; 16(4):281-94. PubMed ID: 10807034
[TBL] [Abstract][Full Text] [Related]
18. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
Basavarajappa BS; Hungund BL
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
[TBL] [Abstract][Full Text] [Related]
19. High-affinity alpha-aminobutyric acid A/benzodiazepine ligands: synthesis and structure-activity relationship studies of a new series of tetracyclic imidazoquinoxalines.
Mickelson JW; Jacobsen EJ; Carter DB; Im HK; Im WB; Schreur PJ; Sethy VH; Tang AH; McGee JE; Petke JD
J Med Chem; 1996 Nov; 39(23):4654-66. PubMed ID: 8917654
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols.
Huffman JW; Miller JR; Liddle J; Yu S; Thomas BF; Wiley JL; Martin BR
Bioorg Med Chem; 2003 Apr; 11(7):1397-410. PubMed ID: 12628666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]